Literature DB >> 25111039

Rapid fecal calprotectin (FC) analysis: point of care testing for diagnosing early necrotizing enterocolitis.

Alona Bin-Nun1, Christina Booms2, Naama Sabag3, Refael Mevorach3, Nurit Algur3, Cathy Hammerman1.   

Abstract

OBJECTIVE: The aim of this study is to compare fecal calprotectin (FC) levels as measured by a rapid FC assay with those measured by enzyme-linked immunosorbent assay (ELISA) from concurrent stool samples. We also attempted to demonstrate a correlation between elevated rapid assay FC levels and the presence of necrotizing enterocolitis (NEC) and to define a cutoff FC value which could serve as a basis for diagnosing NEC in the future. STUDY
DESIGN: Stool samples were collected for FC analysis at 1 and 3 weeks postnatally and whenever there was clinical suspicion of NEC.
RESULTS: Rapid assay FC levels were elevated with NEC (3,000 µg/g stool [2075,7875] vs. without (195 µg/g stool [110,440] p < 0.001); and were well correlated with ELISA FC levels (r(2) = 0.89).
CONCLUSION: We present the first data showing that rapid assay FC levels are potentially useful in the bedside diagnosis of NEC. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25111039     DOI: 10.1055/s-0034-1384640

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  9 in total

Review 1.  The Microbiome and Biomarkers for Necrotizing Enterocolitis: Are We Any Closer to Prediction?

Authors:  Brigida Rusconi; Misty Good; Barbara B Warner
Journal:  J Pediatr       Date:  2017-06-29       Impact factor: 4.406

Review 2.  Calprotectin levels in necrotizing enterocolitis: a systematic review of the literature.

Authors:  Vasilios Pergialiotis; Panagiotis Konstantopoulos; Nikoleta Karampetsou; Diamanto Koutaki; Eleana Gkioka; Despina N Perrea; Nikolaos Papantoniou
Journal:  Inflamm Res       Date:  2016-06-21       Impact factor: 4.575

Review 3.  New insights into necrotizing enterocolitis: From laboratory observation to personalized prevention and treatment.

Authors:  David J Hackam; Chhinder P Sodhi; Misty Good
Journal:  J Pediatr Surg       Date:  2018-06-18       Impact factor: 2.545

4.  Elevated fecal calprotectin levels during necrotizing enterocolitis are associated with activated neutrophils extruding neutrophil extracellular traps.

Authors:  B C MacQueen; R D Christensen; C C Yost; D K Lambert; V L Baer; M J Sheffield; P V Gordon; M J Cody; E Gerday; R Schlaberg; J Lowe; J G Shepherd
Journal:  J Perinatol       Date:  2016-07-07       Impact factor: 2.521

5.  International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases.

Authors:  Ferdinando D'Amico; David T Rubin; Paulo Gustavo Kotze; Fernando Magro; Britta Siegmund; Taku Kobayashi; Pablo A Olivera; Peter Bossuyt; Lieven Pouillon; Edouard Louis; Eugeni Domènech; Subrata Ghosh; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2021-05-07       Impact factor: 4.623

6.  Short-term surgical outcomes of preterm infants with necrotizing enterocolitis: A single-center experience.

Authors:  Qingfeng Sheng; Zhibao Lv; Weijue Xu; Jiangbin Liu; Yibo Wu; Jingyi Shi; Zhengjun Xi
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

Review 7.  Recent Potential Noninvasive Biomarkers in Necrotizing Enterocolitis.

Authors:  Kewei Wang; Guozhong Tao; Zhen Sun; Karl G Sylvester
Journal:  Gastroenterol Res Pract       Date:  2019-04-22       Impact factor: 2.260

8.  Gene expression profiling in necrotizing enterocolitis reveals pathways common to those reported in Crohn's disease.

Authors:  Éric Tremblay; Marie-Pier Thibault; Emanuela Ferretti; Corentin Babakissa; Valérie Bertelle; Marcos Bettolli; Karolina Maria Burghardt; Jean-François Colombani; David Grynspan; Emile Levy; Peng Lu; Sandeep Mayer; Daniel Ménard; Olivier Mouterde; Ingrid B Renes; Ernest G Seidman; Jean-François Beaulieu
Journal:  BMC Med Genomics       Date:  2016-01-22       Impact factor: 3.063

Review 9.  The immunological landscape in necrotising enterocolitis.

Authors:  Steven X Cho; Philip J Berger; Claudia A Nold-Petry; Marcel F Nold
Journal:  Expert Rev Mol Med       Date:  2016-06-24       Impact factor: 5.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.